Ristocetin induces unique ultrastructural changes in human platelets during aggregation, distinct from ADP or collagen.
Answers are grounded in this paper and cite their sources.
May refine in vitro platelet assays; leaves open in vivo validation in animal models.
The effects of ristocetin on human platelets were investigated by aggregometry and electron microscopy. We confirmed the finding that ristocetin induces platelet aggregation. Biphasic platelet aggregation, such as is observed with ADP, was also seen with ristocetin. The gross appearance of ristocetin aggregated specimens differed markedly from those induced by ADP or collagen. On electron microscopic examination the boundaries of the aggregated platelets were noted to be extremely tortuous with electron dense lines between membranes, and there were many swollen α‐granules. At the periphery of the aggregates, the platelets were markedly degranulated. The plasma membranes of degranulated platelets were occasionally lysed. Morphological alterations of platelets exposed to ristocetin appeared to continue even after maximum aggregation, as recorded in the aggregometer, had been achieved.
No takes yet. Share an insight, caveat, or question.
Ts'ao et al. (1973) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: